16.8 USD
+0.25 (+1.51%)
At close: Feb 6, 2026
16.9202 USD
+0.12 (+0.72%)
After Hours: 2/6/2026, 8:00:01 PM
ChartMill assigns a Buy % Consensus number of 84% to DYN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 41.48. This target is 146.9% above the current price.
- DYN was analyzed by 20 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about DYN.
- In the previous month the buy percentage consensus was at a similar level.
- DYN was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-12-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-12-11 | Stifel | Maintains | Buy -> Buy |
| 2025-12-10 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-12-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-12-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-14 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-12 | Oppenheimer | Maintains | Perform -> Perform |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-10 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-08-25 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-08-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | Stifel | Maintains | Buy -> Buy |
| 2025-07-29 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-29 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-07-15 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-06-26 | Jones Trading | Initiate | Buy |
| 2025-06-18 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-03-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | BMO Capital | Initiate | Outperform |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
DYNE THERAPEUTICS INC / DYN FAQ
What do analysts expect the price target to be for DYNE THERAPEUTICS INC (DYN)?
20 analysts have analysed DYN and the average price target is 41.48 USD. This implies a price increase of 146.9% is expected in the next year compared to the current price of 16.8.
Can you provide the consensus rating for DYNE THERAPEUTICS INC stock?
The consensus rating for DYNE THERAPEUTICS INC (DYN) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for DYNE THERAPEUTICS INC stock?
The number of analysts covering DYNE THERAPEUTICS INC (DYN) is 20.